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Abstract 
Pig and rhesus monkey 5-HT2A receptor cDNA clones were isolated. The pig and rhesus monkey clones encode proteins that share a 
94% and 95% homology, respectively, with the rat 5-HTzA receptor, and a 97% and > 99% homology, respectively, with the human 
5-HTzA receptor. Within the transmembrane regions of the pig and monkey receptors, the deduced amino acid shows only three 
differences compared to that of the rat and are identical to the human 5-HT2a receptor clone. 
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The 5-HT2A receptor was one of the first three 5-HT 
receptors to be cloned. The amino acid sequence of the rat 
[1-3], hamster [4] mouse [5] and more recently the human 
[5-9]  5-HTzA receptors have been reported. The homology 
of these 5-HT2A receptor sequences between the different 
species is quite high with only three amino acid changes 
found within the transmembrane (TM) regions, where 
ligand binding is thought o occur (for a review see [10]). 
Despite the high degree of homology, there are well 
documented differences in the pharmacological profile of 
the rat and human 5-HT2~ receptors [11-13]. 
Previously it was found that mesulergine and methy- 
sergide (ergolines that act as antagonists at the 5-HT2A 
receptor) had different affinities for the rat 5-HTzA recep- 
tor than for the pig or human 5-HTzA receptors [11-13]. 
Recent work has identified a very specific structure-activ- 
ity relationship difference among the 5-HTzA receptors of 
various species [12,13]. These studies have indicated that 
N(1) alkyl substitution of indole-containing li ands either 
increases or does not effect he affinity for the rat 5-HT2A 
receptor but significantljy decreases affinity for the pig, 
squirrel monkey and human 5-HT2A receptors. 
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The present study was undertaken for two reasons. 
First, to determine whether the same pharmacological pro- 
file for 5-HTzA receptor ligands would be seen with rhesus 
monkey frontal cortex as has been previously reported for 
the pig, squirrel monkey and human 5-HTzA receptors. 
Secondly, cDNA clones encoding the 5-HTzA receptor in 
pig and rhesus monkey were isolated and sequenced to 
determine and compare the amino acid sequence homolo- 
gies of the 5-HT2A receptor in the rat, human, pig and 
rhesus monkey. 
Materials were obtained from the following sources. 
[3 H]Ketanserin and [ a-32 P]dCTP was obtained from New 
England Nuclear (Boston, MA) at a specific activity of 60 
and 3000 Ci/mmol, respectively. Ketanserin HC1, spiper- 
one HC1, ergonovine maleate, mesulergine HC1, metergo- 
line and LY53857 maleate were purchased from Research 
Biochemicals Inc. (Natrick, MA). All other compounds 
were synthesized at Lilly Research Laboratories (Indiana- 
polis, IN). A cDNA encoding the rat 5-HTzA receptor [2] 
was kindly provided by Dr. Lei Yu (Indiana University- 
Purdue University of Indianapolis, Indianapolis, IN). 
Affinity for the rhesus monkey 5-HTzA receptor was 
examined as described by Nelson et al. [12] with only 
minor modifications. Specifically, rhesus monkey brains 
were obtained from the Texas Primate Center (Alice, TX) 
and the anterior one third utilized in these studies. The 
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tissue was prepared as described [12] and then resuspended 
after the final wash in 50 mM Tris-HC1 (pH 7.6) at 25 mg 
wet wt. /ml and frozen at - 70 ° C until used. Assays were 
automated using a Biomek 1000 (Beckman Instruments, 
Fullerton, CA) in a final volume of 250 /zl. Radioligand, 
25 /xl of 1 nM (final concentrations) in displacement 
experiments or 25 /xl of 0.2 to 10 nM in saturation 
experiments, was added to buffer and varying concentra- 
tions of drugs (dissolved in H20)  such that the final buffer 
consisted of 50 mM Tris-HCl (pH 7.6), with 100 nM 
prazosin. Non-specific binding was defined as that dis- 
placeable with 3 /xM spiperone. Incubations were com- 
menced with the addition of 100/zl tissue homogenate and 
allowed to equilibrate at 37°C for 30 min before filtering 
through GF/B  filters presoaked in 0.5% polyethylenimine. 
Saturation and displacement results were analyzed as pre- 
viously described [ 12,13]. 
Standard cDNA cloning procedures were utilized essen- 
tially as described in the methods of Kursar et al. [14] with 
minor modifications. Pig and rhesus monkey cDNA li- 
braries were obtained from Clontech (San Francisco, CA). 
These libraries had undergone 1 round of amplification. 
The libraries were plated at a density of 5 • 105 pfu/plate 
on 150 mm dishes using standard procedures. The nitro- 
cellulose filters obtained from plaque lifts were prehy- 
bridzed at 45 ° C overnight in 30% formamide, 5 × SSPE, 
5 ×Denhardt's, 0.1% SDS, and 100 /xg/ml denatured 
salmon sperm DNA. A radiolabelled probe was synthe- 
sized by PCR labeling as previously described [15] using 
the cDNA encoding the rat 5-HT2A receptor as a template. 
Hybridization was carried out at 45°C for 48 h and then 
the filters washed three times for 10 rain at 45°C in 
2 X SSC/0.1% SDS and then washed three times for 30 
min at 45°C in 0.1 × SSC/0.1% SDS. Several clones 
were isolated from each library and the clones bearing the 
largest cDNA inserts were further analyzed. It was found 
that the cDNA clones contained an internal EcoRI  site (the 
enzyme used in the library construction). Therefore, the 
resulting fragments were each isolated and subcloned into 
pSport vector (Gibco BRL, Gaithersburg, MD) for further 
analysis. The cDNA clones were sequenced using the ABI 
373 Automated Sequencer (ABT, Foster City, CA) and the 
procedures provided by the vender. The University on 
Wisconsin GCG software was utilized for all sequencing 
analysis. 
Saturation experiments in homogenates from rhesus 
monkey frontal cortex indicated a K d of 0.66 + 0.04 nM 
and a Bma × of 299 + 49 fmol /mg protein (n = 3) for 
[ 3 H]ketanserin. In displacement experiments (Table 1) ke- 
tanserin, spiperone and metergoline were all found to have 
similar affinity for the rat, human, pig squirrel monkey and 
rhesus monkey 5-HT2A receptor [12,13]. The N(I) substi- 
tuted ergolines, mesulergine and LY53857, have a lower 
affinity for the rhesus monkey 5-HT2A receptor than the rat 
receptor (Table 1). In contrast, the N(1) unsubstituted 
ergolines, ergonovine and LY86057, have a higher affinity 
for the rhesus monkey 5-HT2A receptor than the rat recep- 
tor. All of these ergolines were found to have affinities for 
the rhesus monkey that were very similar to those found 
for the squirrel monkey, pig and human receptors. 
The nucleotide sequence of the rhesus monkey clone 
isolated from the cDNA library appeared to contain a 
deletion of one nucleotide in the region encoding the 
carboxy terminus. A series of adenosines found at posi- 
tions 1283 to 1289 contained one less base than seen in 
any other 5-HT2A receptors. It was hypothesized that the 
apparent deletion of a single base pair within this region 
(1283-1290) was due to an error in the synthesis of cDNA 
with reverse transcriptase. To test this hypothesis, a 400 
base pair DNA fragment was amplified from rhesus mon- 
key genomic DNA (Clontech, San Francisco, CA) by PCR 
using standard procedures and sequenced. The resulting 
PCR product confirmed a string of 7 adenosines consistent 
with the other 5-HT2A receptor sequences (as opposed to 6 
found in the A phage clone). Therefore, it is presumed that 
the isolated cDNA clone sequence contained an unnatural 
deletion and the corrected sequence (as given in Fig. 2) 
was used for all subsequent analysis. 
Table 1 
Affinity for [3H]ketanserin-labeled rh sus monkey 5-HT2A receptors infrontal cortex homogenates 
Drug N(1) subst. IC50 (nM) 
Rhesus monkey a Rat b Squirrel monkey b Pig b Human b 
Ketanserin 3.35 _+ 0.09 2.49 4.28 1.70 
Spiperone 2.16 4- 0.26 0.92 c (_+0.05) 
Metergoline -CH 3 1.19 _+ 0.04 0.76 0.82 0.37 1.2 
Ergonovine -H 3.22 + 0.99 46.4 3.4 3,8 3.1 
Mesulergine -CH(CH3) 2 45.9 _+ 10.3 8.2 44.9 54.2 48.5 
LY86057 -H 4.20 _+ 0.30 55.9 3.2 4,6 3.3 
LY53857 -CH(CH3) 2 57.5 _ 3.8 7.2 33.1 40.0 30.6 
ICs0 values were determined bydisplacement of 1.0 nM [3H]ketanserin as described previously [12]. The ICs0 values for displacement from rat, squirrel 
monkey, pig and human [3H]ketanserin-labelled 5-HTzA receptors were included for comparison [12]. 
Mean _+ S.E. (n). 
b Taken from [12]. 
Nelson, D.L., Wainscott, B.D. and Lucaites, V.L., unpublished results. 
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The cDNA sequence ncoding the pig and rhesus mon- 
key 5-HT2A receptors are given in Figs. 1 and 2, respec- 
tively. At the nucleotide level the pig 5-HTzA receptor has 
85% homology to the rat and 91% homology to the human 
analogue of this receptor. Similarly the rhesus monkey 
5-HTzA receptor has 87% homology to the rat and 98% 
homology to the human analogue of this receptor. A 
multiple sequence alignment of the deduced amino acids 
indicates a high homology to the rat 5-HTzA receptor (94% 
and 97%, for the pig and rhesus monkey, respectively) and 
an even higher homology to the human 5-HT2A receptor 
(95% and > 99% for the pig and rhesus monkey, respec- 
tively). Within the TM regions, the pig and rhesus monkey 
sequences are identical to the human amino acid sequence 
but differ by three amino acids from that of the rat 
sequence (Fig. 3). 
Previous work using mutagenesis of the human and rat 
5-HT2A receptors has suggested that the changes in struc- 
ture-activity relationship seen when examining different 
species are due to a single amino acid difference between 
the rat and human 5-HT2A receptor. Kao and co-workers 
[16] found that by mutating Ser-242 in the TM V region of 
the human 5-HT2A receptor to Ala-242 there was an 
increase in the affinity for [3H]mesulergine while the 
affinity for [3H]ketanserin was unaffected. Specifically, 
[3H]mesulergine was found to have an affinity for the 
mutated 5-HT2A receptor that was very similar to the rat 
but different than the wild-type human 5-HT2A receptor. 
0 20 40 60 
1 M D V L C E E N T S L S S P T N S F M Q L N D D T 27 
80 100 120 140 
; ~GGCTC TACCATAACGACTITAAC~gC~GAAGCTAACACTTCAGAC GCATITAA~CCGTGGACTCAGAAAATC 
27 R L Y H N D F N S G E A N T S D A F N W T V D S E N R 53 
160 180 200 220 
C ~AACCAACCTITCC~TGAGGGC' I~TCTCTCACCACCCTGCTTCTC C ~TCTCCAGGAAAAAAACTGGTCTGC C 
54 T N L S C E G C L S P P C F S L L H L Q E K N W S A 80 
240 260 280 300 
~T I~3TTGACAGCTGTAGTGATTATCCTGACCA~CATACTCGTCATCA~GTGTCC CTAGAGAAAAAGCT 
81 L L T A V V I I L T I A G N I L V I M A V S L E K K L 107 
320 340 360 380 
( XZAGAATGC AC CAACTATTTC CTGATGTCACTTC~ CATAGC GGATATGCTGCTGC43T'FI~ CTI~rgCATGCCTGTGTCCA 
107 Q N A T N Y F L M S L A I A D M L L G F L V M P V S M 133 
400 420 440 460 
~ ~TTAACCATTCTCTATGGGTACCC-GTGGCCTCTC-C C AGCAAGCTCTGCGCCG~C TGGATTTATCTGGATGTGC~ 
134 L T I L Y G Y R W P L P S K L C A V W I Y L D V L F 160 
480 500 520 540 
~ X~CACGGC TCCATCATGCACCTCTGTGCCATCTC GCTC-GACCGCTATGTTGCCATC CAGAACCCCATCCATCACAGGCG 
161 S T A S I M H L C A I S L D R Y V A I Q N P I H H R R 187 
560 580 600 620 
ATTCAACTCTAC=AACTAAGGCA~fTCTC_~AAATAATTGCTG~q~PGGACTATATCAGTAGGTATCTC CATGCCAATCC C TG 
187 F N S R T K A F L K I I A V W T I S V G I S M P I P V 213 
640 660 680 700 
~3~TCCAGGATGATTCCAAGGTCTTCAAGGAAGGGAGCTGCTTACTTGCGGATGATA~I '± ' I ' IGTCCTGATI~-GC 
214 F G L Q D D S K V F K E G S C L L A D D N F V L I G 240 
720 740 760 780 
[ ~C'FI'I'±~TGTCATTTTTCATTCCCTTAAC CATCATGGTC=ATCACCTACTTTCTAACCATCAAGTCACTCCAGAAAGAAGC 
241 S F V S F F I P L T I M V I T Y F L T I K $ L Q K E A 267 
800 820 840 860 
[ ?ACTTTGTGTGTGAGTGATCTTGGGACACC.GC.C~AAGTTAGCT~CTTTCAC.CTTCCTCCCTCAGAGCTCCCTGTC~TCCG 
267 T L C V S D L G T R A K L A S F S F L P Q S S L S S E 293 
880 900 920 940 
~ LAAAGCTCTTCCAGCGGTC ATC CACAGGGAGCCAGGCTCCTACGGCAGGAGGACTATGCAGTCCATCAGCAACGAGCAG 
294 K L F Q R S I H R E P G S Y G R R T M Q S I S N E Q 320 
960 980 i000 1020 
AAGGCGTGCAAGGTGC~TAGTCTI 'CTTTCTGTTCGTC~GTGA%~'TGGTC-C  C CTTCTTCATCAC CAACATCATGGC 
321 K A C K V L G I V F F L F V V M W C P F F I T N I M A 347 
1040 1060 1080 ii00 
CGTCATCTGCAAAGAGTCCTGCAACGAGGATGTCATCGGAGC CCTGCTCAACGTGTTCGTI'I~.=GATCGG~ACC ~ C T  
347 V I C K E S C N E D V I G A L L N V F V W I G Y L S S 373 
1120 1140 1160 1180 
C. 'AGCCGTCAACCCGCTAGTGTACACACTGTTCAATAAGACCTACAGGTC GCCTTTI~CCAGGTATATI~CAGTGTCAGTAC 
374 A V N P L V Y T L F N K T Y R S A F S R Y I Q C Q Y 400 
1200 1220 1240 1260 
AAGGAAAATAAAAAACCGCTGCAGTTAATTCTAGTGAACACCATACCGGC ~CTACAAGTCTAGTCAACTC CAAAC 
401 [{ E N K K P L Q L I L V N T I P A L A Y K S S Q L Q T 427 
1280 1300 1320 1340 
GGGACAAAAAGAGAATrCAAAGCAAGACGACAAGGC CA AGAAAACGACTGCAC TATGGTTGCTC TAGGAAAACAACAq~f 
427 G Q K E N S K Q D D K A T E N D C T M V A L G K Q H S 453 
1360 1380 1400 1420 
2AGAAGATGCTCCTC-CAGACAATAGCAACACAGq~AACGAAAAGGTTAGCTGTGTATGATGGAGTC~G~C 
454 E D A P A D N S N T V N E K V S C V * 477 
Fig. h The nucleotide sequence and deduced amino acid sequence encoding the pig 5-HT2A receptor. Sequences were isolated from a cDNA I library 
using a radiolabelled rat 5-HT2~ probe and low stringency hybridization. 
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Recent work [17] has examined a series of ergolines and 
tryptamines, that have previously been identified as having 
species differences in their affinity, at several mutants of 
position 242 in the rat 5-HTzA receptor. The Ala-242 to 
Ser-242 mutant, resulted in affinities for the test com- 
pounds that were significantly different than seen with the 
wild-type rat receptor but practically identical to the hu- 
man 5-HT2A receptor. This clearly indicates that the 
changes in affinity and therefore the differences in struc- 
ture-activity relationship found among the 5-HTzA recep- 
tors of various species are due to the single amino acid 
change within TM V. 
Pharmacological characterization of the pig [12] and 
rhesus monkey (Table l) 5-HT2A receptor have indicated a 
structure-activity relationship with ergolines and 
tryptamines that is very similar to that seen with the 
human but different from that of the rat 5-HTzA receptor. 
Since the mutagenesis studies described above clearly 
implicate an Ala-242 to Ser-242 change between species 
as a cause for these structure-activity relationship differ- 
ences, one would predict that the pig and rhesus monkey 
5-HT2A receptors would have a Ser and not an Ala at 
position 242. This was indeed found to be true. Therefore, 
the present results are consistent with the hypothesis that 
the Ala/Ser change in the 5-HT2A receptor sequences 
result in changes in the structure-activity relationship with 
ergolines and tryptamines. 
One of the obvious implications of the present and 
previous work [l 1-13,16,17] is that the affinity for the rat 
5-HT2A receptor does not serve as a good indicator for 
0 20 40 60 
TGGC TTAGACATGGATATTCTTTGTGAAGAAAATACTTCTTTGAGCTCAACTACGAACTCCTrAA CAATTAAATGAAG 
1 M D I L C E E N T S L S S T T N S L M Q L N E D 27 
80 i00 120 140 
ACACCAGGCTCTACAGTAATGACTTTAACTCCGGAGAAGCTAACACTTCTGATGCATTTAACTGGACAGTCGAGTCTGAA 
27 T R L Y S N D F N S G E A N T S D A F N W T V E S E 53 
160 180 200 220 
AATCGAACCAACCTTrCCTGTGAAGGGTGCCTCTCACCATCGTGTCTCTCCTTAC rCATC TCCAGGAAAAAAACTGGTC 
54 N R T N L S C E G C L S P S C L S L L H L Q E K N W S 80 
240 260 280 300 
TGCTTTATTGACAC-CTGTAGTGATTATTC"rAAccATTC`CTGGAAACATAcTCGTCATCATGC`CAGTGTC••TAGAGAAAA 
81 A L L T A V V I I L T I A G N I L V I M A V S L E K K 107 
320 340 360 380 
AGCTGCAGAATGC ACCAACTATI ' I~CTGATGTCACTTGCCATAGCTGATATGC TC~CTTGTCATC-CCCGTG 
107 L Q N A T N Y F L M S L A I A D M L L G F L V M P V 133 
400 420 440 460 
TCCATGTTAACCATCCTGTATGGGTACC~CTCTC-CCCAGCAAGC%~'~GCGCGGTC TGGATTTAC CTAGACGTGCT 
134 S M L T I L Y G Y R W P L P S K L C A V W I Y L D V L 160 
480 500 520 540 
CTTCTCCACGGCCTCCATCATGCACCTCTGC CCATCTCGCTGGACCGCTATGTCC-CCATCCAGAATCCCATC CA CACA 
161 F S T A S I M H L C A I S L D R Y V A I Q N P I H H S 187 
560 580 600 620 
GC CGC~CTCCAGAACTAAGGCATq ' I~TGAAAATCATTGCTGTI ' I~GACCATATCAGTAGGTATATCGATGCCAATA 
187 R F N S R T K A F L K I I A V W T I S V G I S M P I 213 
640 660 680 700 
CCAGTCT~ACAGGACGATTCGAAGGTCTTTAAGGAGGGGAGTTC-CTTACTCGCCGATGATAACTq~TGT~T 
214 P V F G L Q D D S K V F K E G S C L L A D D N F V L I 240 
720 740 760 780 
CGGCTC 1"r ±'IGTGTCA'I'rI'I'ICATTCCCTTGACCATCATC-GTGATCACCTACTTTCTAACTA CAAGTCACTC CA AAAG 
241 G S F V S F F I P L T I M V I T Y F L T I K S L Q K E 267 
800 820 840 860 
AAGCTACTTTGTGTGTAAGTGATCTC -GCACACGGGCCAAATTAGCq~2CTTTCAC-Cqq~ CTCCCTCAGAGTTCTq'DGTCT 
267 A T L C V S D L G T R A K L A S F S F L P Q S S L S 293 
880 900 920 940 
TCAGAAAAGCTGTI~CAGCGGTCGATCCACAGGGACCCAGGGTCCTACACAGGCAGAAGGACTATGCAGTC CATCAGCAA 
294 S E K L F Q R S I H R D P G S Y T G R R T M Q S I S N 320 
960 980 i000 1020 
TGAGCAAAAGGCATGCAAGGTC-CTGGGTATCGTC~FFCq~fC C TGTTTGTGGTGATGTGGTC-CCC%~FI~q 'PCA~A~ 
321 E Q K A C K V L G I V F F L F V V M W C P F F I T N I 347 
1040 1060 1080 1100 
TCATGGCCGTCATCq~qL~%AGAGTCTTGCAATGAGGATG TTGGGGCCCTGCTCAATGTGT'FDGTTTGGATCGGTTAT 
347 M A V I C K E S C N E D V I G A L L N V F V W I G Y 373 
1120 1140 1160 1180 
CTCTCTTCAC-CAGTCAAC CCACTGGTCTACACACTG~'I~.AACAAGACTTATAC~3TCAGCCTTTTCACGGTATATTCAGTG 
374 L S S A V N P L V Y T L F N K T Y R S A F S R Y I Q C 400 
1200 1220 1240 1260 
TCAGTACAAGGAAAACAAAAAAC CA~AG %~fAA'/" L" I " I~GTGAA~CTATACCGGCTTTGGCCTACAAGTCTAGCCAAC 
401 Q Y K E N K K P L Q L I L V N T I P A L A Y K S S Q L 427 
1280 1300 1320 1340 
TTCAAA .GAATTCAAAGCAAGATC-CCAAGACAACAGATAATGACTGCTCAATGGTTGCTCTAGGAAAG 
427 Q M G Q K K N S K Q D A K T T D N D C S M V A L G K 453 
1360 1380 1400 1420 
CAGCATTCTGAAGATGCTTCTAAAGACAATAGCGACGGAGTGAATGAAAAGGTGAGCTGTGTGTGACAGGCCAG~ 
454 Q H S E D A S K D N S D G V N E K V S C V * 479 
Fig. 2. The nucleotide sequence and deduced amino acid sequence encoding the rhesus monkey 5-HT2A receptor. Sequences were isolated from a cDNA l 
library using a radiolabelled rat 5-HT2A probe and low stringency hybridization. 
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affinity to the human 5-HT2A receptor. Admittedly, with 
most 5-HT2A ligands there is no difference in affinity for 
the rat and human receptors and to date the only 5-HT2A 
ligands that have shown species differences are of a spe- 
cific structural type (i.e., indole containing compounds). 
However, the fact that some compounds do show species 
differences between the rat and the pig, squirrel monkey, 
rhesus monkey and human, and that the structure-activity 
relationship actually reverses between these species [12,13] 
means that the results from rat cannot be used with a high 
degree of confidence to predict activity in humans. Fur- 
thermore, if the affinity of a compound for one receptor 
(for example the 5-HT2A receptor) changes between species 
it does not necessarily follow that the affinity of the 
compound will change fix any other receptor (for example 
the 5-HT2c receptor). Therefore, one may have a de- 
creased or even a loss of selectivity for a target resulting in 
an increase chance for side effects in man. 
With the 5-HT2A receptor it is now clear that the 
species differences obse~ved in affinities for ergolines and 
tryptamines is due to a single amino acid substitution, 
Ala/Ser-242 [16,17]. However, there are two other amino 
acid substitutions within the TM regions of the rat and the 
pig, rhesus monkey and human 5-HTzA receptors. The 
Ile-150 in the rat to Val-150 in the higher species is less 
likely to result in significant changes in the ability of 
compounds to bind to these receptors. However, the rat 
5-HT2A receptor contains a Thr-82 while the pig, rhesus 
monkey and human 5-HT2A receptors have an Ala in this 
position. It is easy to envision an H-bonding interaction 
occurring in the rat if this Thr were positioned in the 
appropriate site within the binding pocket. Naturally this 
H-bonding interaction would be lost in the pig, rhesus 
monkey and human 5-HT2A receptors. Although no such 
compounds have been identified, it is possible that com- 
pounds other than the ergolines and tryptamines could 
potentially show species differences in their affinity for the 
5-HT2A receptor. 
One obvious solution to this potential problem of species 
specific affinities is to utilize rhesus monkey frontal cortex 
or the pig frontal cortex, or the pig, rhesus monkey or 
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281 
Mon5ht2 FSFLPQSSLS SEKLFQRSIH 
Hum5ht2 FSFLPQSSLS SEKLFQRSIH 
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350 
~PG~RR TMQSISNEQK ACKVLGIVFF LFVVMWCPFF ITNIMAVICK 
~PG~RR TMQSISNEQK ACKVIX~IVFF LFVVMWCPFF ITNIMAVICK 
~PG~RR TMQSISI~K ACKVLGIVFF LFVVMWCPFF ITNIiKAVICK 
~S~G~ ~QSZS=~QK ACm,U~WF L~'V~CP~ I~V ICK  
TMVH 
351 
Mon5ht2 ES~GA LLNVFVWIGY LSSAVNPLVY 
Hum5ht2 ES~GA LLNVFVWIGY LSSAVNPLVY 
Pig5ht2 ESCI~GA LLNVFVWIGY LSSAVNPLVY 
Rat5ht2 ES~GA LI/IVFVWIGY LSSAVNPLVY 
420 
TLFNKTYRSA FSRYIQCQYK ~LQL IL  VNTIPALAYK 
TLFITKTYRSA FSRYIQCQYK ~LQL IL  VNTIPALAYK 
TLFIqI<TYRSA FSRYIQCQYK E~LQL IL  VNTIPALAYK 
~TYRSA FSRYIQCQYK ~LQL IL  VNTIPALAYK 
421 472 
N' i K ~S Mon5ht2 SSQL~GQ~ ~   ~ S C  V* 
H~shtz  ssQu~Q~ N ~, K ~ s c  v* 
Pig5ht2 SSQ_L~___~, ~ 
,, V* 
Fig. 3. Multiple alignment comparison of deduced amino acid sequences from the human, pig, rhesus monkey and rat 5-HT2A receptors. Shaded areas 
indicate species differences irL the amino acid sequence. 
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5-HTzA receptor. Previous work [12,13,17] has clearly 
shown that those compounds that do show species differ- 
ences in affinity have a similar affinity for the pig, rhesus 
monkey and human 5-HTzA receptors uggesting that the 
rhesus monkey and pig serve as appropriate models for 
affinity to the human 5-HT2A receptor. The present report 
greatly strengthens this argument by deducing the amino 
acid sequence of the pig and rhesus monkey 5-HT2A 
receptors from cDNA clones. The fact that the pig, rhesus 
monkey and human 5-HT2A receptors have identical amino 
acid sequences within the TM regions and that all the 
modeling and mutagenesis work to date indicate that 5- 
HT2A receptor ligands bind within a pocket formed by the 
TM regions strongly suggests no compounds will be found 
that bind with a different affinity to the pig, rhesus monkey 
and human 5-HT2A receptors. Therefore, either the rhesus 
monkey or the pig 5-HT2A receptors could serve as more 
reasonable models to predict affinity to the human 5-HT2A 
receptor. 
The authors would like to thank Stanly G. Bergett for 
sequencing the cDNA clones. 
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